Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
134.4 USD | -0.69% | +5.53% | +6.69% |
Chart calendar Ascendis Pharma A/S
Upcoming events on Ascendis Pharma A/S
Past events on Ascendis Pharma A/S
2024-06-03 02:25 pm | Endocrine Society Meeting |
2024-06-03 12:00 pm | Endocrine Society Meeting |
2024-06-02 09:30 am | Endocrine Society Meeting |
2024-05-13 06:40 am | European Endocrinology of Congress |
2024-05-12 08:50 am | European Endocrinology of Congress |
2024-05-02 04:30 pm | Q1 2024 Earnings Call |
2024-05-02 04:01 pm | Q1 2024 Earnings Release |
2024-03-11 02:00 pm | Leerink Partners Global Biopharma Conference |
2024-02-13 04:00 pm | Oppenheimer Healthcare Life Sciences Conference |
2024-02-07 04:30 pm | Q4 2023 Earnings Call |
2024-02-07 04:01 pm | Q4 2023 Earnings Release |
2024-01-08 12:00 pm | JPMorgan Healthcare Conference |
2023-11-07 04:30 pm | Q3 2023 Earnings Call |
2023-11-07 04:01 pm | Q3 2023 Earnings Release |
2023-10-15 | American Association of Bone & Mineral Research Meeting - Poster No - #1114 |
2023-09-20 | European Society for Paediatric Endocrinology Meeeting - Poster Number: LB-17 |
2023-09-12 12:55 pm | Morgan Stanley Global Healthcare Conference |
2023-09-08 08:00 am | Wells Fargo Healthcare Conference |
2023-09-07 02:40 pm | Citi BioPharma Conference |
2023-09-05 04:30 pm | Q2 2023 Earnings Call |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 13,4 12,4 8.01% | 6,95 8,81 -21.06% | 7,78 6,54 18.86% | 51,2 45,5 12.57% | 267 216 23.67% | 443 |
EBITDA Million EUR | Released Forecast Spread | -220 -214 -2.66% | -321 -301 -6.59% | -436 -436 -0.17% | -544 -535 -1.62% | -437 -506 13.77% | -189 |
EBIT Million EUR | Released Forecast Spread | -227 -219 -3.4% | -331 -308 -7.41% | -452 -453 0.36% | -562 -556 -1.13% | -456 -516 11.77% | -195 |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -218 -196 -11.37% | -419 -353 -18.58% | -384 -408 5.85% | -578 -543 -6.35% | -474 -471 -0.57% | -270 |
Net income Million EUR | Released Forecast Spread | -218 -196 -11.43% | -419 -354 -18.23% | -384 -406 5.5% | -583 -530 -10.02% | -481 -493 2.26% | -285 |
EPS EUR | Released Forecast Spread | -4,69 -4,18 -12.11% | -8,28 -6,98 -18.6% | -7,00 -7,49 6.52% | -10,4 -9,56 -8.82% | -8,55 -8,63 0.95% | -4,91 |
Announcement Date | 01/04/20 | 10/03/21 | 02/03/22 | 16/02/23 | 07/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 6,83 4,47 52.64% | 6,16 5,81 6.02% | 15,3 8,81 73.57% | 22,9 18,8 21.49% | 33,6 21,5 56.04% | 47,4 37,4 26.84% | 48,0 48,0 0.09% | 138 85,6 60.86% | 95,9 81,7 17.38% | 87,9 | 110 | 147 | 169 | 190 |
EBITDA Million EUR | Released Forecast Spread | -124 -116 -6.56% | -138 -110 -24.56% | -140 -122 -14.88% | -139 -140 0.61% | -130 -128 -1.3% | -31,6 -40,0 20.92% | -44,7 -75,5 40.82% | -51,1 | -41,2 | -30,0 | ||||
EBIT Million EUR | Released Forecast Spread | -128 -117 -9.15% | -142 -128 -11.25% | -145 -143 -1.02% | -147 -144 -2.29% | -144 -150 4.34% | -141 -144 2.16% | -134 -135 0.6% | -36,6 -97,9 62.61% | -49,1 -82,5 40.42% | -68,0 | -51,2 | -23,9 | -12,1 | 1,00 |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -125 -118 -6.41% | -81,4 -129 36.95% | -169 -140 -20.97% | -202 -149 -35.55% | -110 -153 28.57% | -122 -141 13.32% | -162 -128 -26.16% | -81,1 -71,9 -12.84% | -129 -79,6 -61.49% | -69,1 | -51,1 | -25,4 | 8,00 | 9,00 |
Net income Million EUR | Released Forecast Spread | -125 -115 -8.71% | -81,3 -120 31.99% | -169 -142 -19.17% | -207 -138 -50.04% | -111 -153 27.52% | -121 -144 15.61% | -162 -133 -21.99% | -86,9 -93,2 6.82% | -131 -83,1 -57.74% | -73,4 | -57,0 | -27,1 | 8,00 | 7,00 |
EPS EUR | Released Forecast Spread | -2,21 -1,99 -10.85% | -1,46 -2,11 30.81% | -3,03 -2,53 -19.95% | -3,70 -2,48 -49.06% | -1,98 -2,71 26.97% | -2,16 -2,56 15.63% | -2,88 -2,35 -22.52% | -1,54 -1,57 2.15% | -2,30 -1,44 -59.53% | -1,28 | -0,99 | -0,47 | 0,15 | 0,13 |
Announcement Date | 11/05/22 | 10/08/22 | 02/11/22 | 16/02/23 | 27/04/23 | 05/09/23 | 07/11/23 | 07/02/24 | 02/05/24 | - | - | - | - | - |
Past sector events for Ascendis Pharma A/S
2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 08:00 am | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ASND Stock
- Calendar Ascendis Pharma A/S